The acute effect of monoamine oxidase inhibitors on serotonin conversion to melatonin

5-Hydroxytryptamine in Psychiatry: A Spectrum of Ideas

Volumn , Issue , 2012, Pages

  Oxenkrug, Gregory F ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Antidepressants; Catabolism; Melatonin biosynthesis; Monoamine oxidase; N acetylation; Pinealocyte adrenoceptors

Indexed keywords

EID: 84939203251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780192620118.003.0008     Document Type: Chapter

References (57)

1. Arendt, J., Bojkowski, C., Folkard, S., Franey, C., Marks, V., Moniors, D., Waterhouse, J., et al. (1985). Some effects of melatonin and the control of its secretion in humans. In Photoperiodism, melatonin and pineal, Ciba Foundation Symposium 117, (ed. D. Evered and S. Clark), pp. 266-79. Pitman, London.
2. Armstrong, S. M., Cassone, V. M., Chesworth, M. J., Redman, J. R., and Short, V. (1986). Synchronization of mammalian circadian rhythms by melatonin. Journal of Neural Transmission, S21, 373-96.
3. Axelrod J., Shein X., and Wurtman, R. J. (1969). Stimulation of 14-C melatonin synthesis from 14-C-tryptophan by noradrenaline in rat pineal organ culture. Proceedings of the National Academy of Sciences USA, 62, 544-9.
4. Bade, P., Rommerspacher, H., and Strauss, S. (1977). N-acetyltransferase activity in pineal gland of rats treated with pargyline. Archives of Pharmacology, 297, 143-7.
5. Belanger, P-M. and Atitse-Gbeassor, A. (1982). The inhibitory effect of tranylcypromine on hepatic drug metabolism in the rat. Biochemical Pharmacology, 31, 2679-83.
6. Bieck. P. R., Antonin, K. H., Balon, R., and Oxenkrug, G. F. (1988). Brofaromine and pargyline effect on human plasma melatonin. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 12, 93-101.
7. Bhattacharya, S. K., Glover, V., Mclntyre, I. M., Oxenkrug, G. F., and Sandler M. (1988). Stress causes an increase in endogenous monoamine oxidase inhibitor (tribulin) in rat brain. Neuroscience Letters, 92, 218-21.
8. Cowen, P. J., Frazer, S., Grahame-Smith, D. G., Green, A. R., and Stanford, C., (1983). The effect of chronic antidepressant administration on βadrenoceptor function of the rat pineal. British Journal of Pharmacology, 78, 89-96.
9. Crane, G., (1957). Iproniazid (Marsilid) phosphate, therapeutic agent for mental disorders and debilitating diseases. Psychiatry Research Reports, 8, 142-52.
10. Deguchi, T. and Axelrod, J. (1972). Induction and superinduction of serotonin Nacetyltransferase by adrenergic drugs and denervation of rat pineal organ. Proceedings of the National Academy of Sciences USA, 69, 2208-11.
11. Demisch, K., Demisch, L., Bochnik, H. J., Nickelsen, T., Althoff, P. H., Schoffling, K., and Rieth R. (1986). Melatonin and Cortisol increase after fluvoxamine. British Journal of Clinical Pharmacology, 22, 620-1.
12. Franey, C., Aldhous, M., Burton, S., Checkley, S., and Arendt, J. (1986). Acute treatment with desipramine stimulates melatonin and 6-sulphatoxy melatonin production in man. British Journal of Clinical Pharmacology, 22, 73-9.
13. Glover, V., Bhattacharya, S. K., Sandler, M., and File, S. M. (1981). Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature, 292, 347-9.
14. Golden, R. N., Markey, S. P., Risby, E. D., Rudorfer, M. V., Cowdry, R. W., and Potter, W. Z. (1988). Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. Archives of General Psychiatry, 45, 150-4.
15. Greenberg, L. H. and Weiss, B. (1978). Beta-adrenergic receptors in aged rat brain reduced number and capacity of pineal gland to develop supersensitivity. Science, 201, 62-3.
16. Heydorn, W. E., Brunswick, D. J., and Frazer, A. (1982). Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum. Journal of Pharmacology and Experimental Therapeutics, 222, 534-43.
17. Illnerova, H. (1974). The effect of darkness and pargyline on the activity of serotonin Nacetyltransferase in the rat epiphysis. Neuroendocrinology, 16, 202-11.
18. Kataoka, Y., Gutman, Y., Guidotti, A., Panula, P., Wroblewski, J., Cosenza-Murphy, D., et al. (1984). Intrinsic GABAergic system of adrenal chromaffin cells. Proceedings of the National Academy of Sciences USA, 81, 3218-22.
19. King, T. S., Richardson, B., and Reiter, R. J., (1982). Regulation of rat pineal melatonin synthesis: effect of monoamine oxidase inhibition. Molecular and Cell Endocrinology, 25, 327-8.
20. Klein, D. and Rowe, J. (1970). Pineal gland in organ culture. I. Inhibition by harmine of serotonin-14-C oxidation accompanied by stimulation of melatonin 14-C production. Molecular Pharmacology, 6, 164-71.
21. Kripke, D. (1983). Phase-advanced theories for affective disorders. In Circadian rhythms in psychiatry, (ed. T. Wehr and F. Goodwin), Vol. 2, pp. 41-69. Boxwood Press, California.
22. Lewy, A. (1983). Biochemistry and regulation of mammalian melatonin production. In The pineal gland, (ed. R. Relkin), pp. 77-128. Elsevier, New York.
23. Loomer, H., Saunders, J., and Kline, N. (1957). Clinical and pharmacodynamic evaluation of iproniazid as psychic energizer. Psychiatry Research Reports, 8, 129-41.
24. Lowenstein, P., Solveyra, C., Sarmiento, M., and Cardinali, D. (1985). Benzodiazepines decreased norepinephrine release from rat pineal nerves by acting on peripheral type binding sites. Acta Physiologica et Pharmacologica Latinoameri-cana, 35, 441-9.
25. Lynch, H. J., Ho, M., and Wurtman, R. J. (1977). The adrenal medulla may mediate the increase in pineal melatonin synthesis induced by stress, but not that caused by exposure to darkness. Journal of Neural Transmission, 40, 87-97.
26. McCauley, R. B. (1981). Monoamine oxidases and the pharmacology of monoamine oxidase inhibitors. In Neuropharmacology of central nervous system and behavioral disorders, pp. 93-109. Academic Press, New York.
27. Mclntyre, I. M., McCauley, R., Murphy, S., Goldman, H., and Oxenkrug, G. F. (1985). The effect of superior cervical ganglionectomy on melatonin stimulation by MAO-A inhibitor. Biochemical Pharmacology, 34, 3394-5.
28. Moore, R. Y. (1974). Central nervous control of circadian rhythms. In Frontiers in neuroendocrinology, Vol. 5, (ed. W. F. Ganong,), pp. 185-205. Raven Press, New York.
29. Murphy, D., Cohen, R., Siever, L., Ray, B., Karoum, F., Wyatt, R., et al. (1983). Clinical and laboratory studies with selective monoamine-oxidase-inhibitory drugs. In Problems in pharmacopsychiatry, Vol 19, pp. 287-303.
30. Karger, Basel. Murphy, D. L., Garrick, N. A., Tamarkin, L., Taylor, P. L., and Markey, S.P. (1985). Effect of antidepressant and other psychotropic drugs on melatonin release and pineal gland function. In Melatonin in humans, (ed. R. J. Wurtman and F. Waldhauser), pp. 261-77. Center for Brain Sciences and Metabolism Charitable Trust, Cambridge, Massachussetts.
31. Murphy, D. L., Tamarkin, L., Sunderland, T., Garrick, N. A., and Cohen, R. (1986). Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl. Psychiatry Research, 17, 119-27.
32. Nowak, J. Z., Przybysz, M., and Zurawska, E. (1988). The melatonin generating system in the rat retina and pineal gland: effect of single and repeated electroconvulsive shock (ECS). Polish Journal of Pharmacology, 40, 573-84.
33. Neuwelt, E. and Lewy, A. (1983). Disappearance of plasma melatonin after removal of a neoplastic pineal gland. New England Journal of Medicine, 308, 1132-5.
34. Oxenkrug, G. F., and Mclntyre, I. M. (1985). Stress-induced synthesis of melatonin:possible involvement of the endogenous monoamine oxidase inhibitor (Tribulin). Life Sciences, 37, 1743-6.
35. Oxenkrug, G. F., and McCauley, R. B. (1987). The effect of MAO inhibitors on melatonin synthesis: mechanism and clinical implication. Pharmacology and Toxicology, 60, Suppl. 1, 36.
36. Oxenkrug, G. F. and Harris P. (1988). Benzodiazepines attenuate clorgyline-induced stimulation of melatonin synthesis. Pharmacology Research Communication, 20, Suppl. 4, 139-40.
37. Oxenkrug, G. F. and Requintina, P. J. (1990). Central but not peripheral benzodiazepine agonists attenuate clorgyline effect on melatonin synthesis. Biological Psychiatry, 27, 68A.
38. Oxenkrug, G., McCauley, R., McIntyre, I., and Filipowicz, C. (1984). Effect of clorgyline and deprenyl on rat pineal melatonin. Journal of Pharmacy and Pharmacology, 36, 55W.
39. Oxenkrug, G., McIntyre, I., McCauley, R., and Filipowicz, C. (1985). Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin. Journal of Neural Transmission, 61, 265-70.
40. Oxenkrug, G. F., Balon, R., Jain, A. K., McIntyre, I. M., and Appel, D. (1986a). Single dose of tranylcypromine increases human plasma melatonin. Biological Psychiatry, 21, 1085-9.
41. Oxenkrug, G. F., McCauley, R. B., Fontana, D. J., McIntyre, I. M., and Commis-saris, R. I. (1986b). Possible melatonin involvement in the hypotensive effect of MAO inhibitors. Journal of Neural Transmission, 66, 271-80.
42. Oxenkrug, G. F., Balon, R., Jain, A. K., and McIntyre, I. M.(1988a). Melatonin plasma response to MAO inhibitor-an index of pineal activity? Acta Psychiatrica Scandinavica, 11, 160-2.
43. Oxenkrug, G., McIntyre, I., McCauley, R., and Yuwiler, A. (1988b). The effect of selective MAO inhibitors on rat pineal melatonin synthesis in vitro. Journal of Pineal Research, 5, 99-109.
44. Oxenkrug, G. F., Balon, R., Kroessler, D., Yeragani, V., Beardsley, G., and Lewy, A. (1989). Single dose administration of tranylcypromine does not change human 6- sulphatoxymelatonin urine excretion. Biological Psychiatry, 25 (7A), 53A.
45. Oxenkrug, G. F., Requintina, P. J., and Yuwiler, A. (1990a). Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do? Journal of Neural Transmission, 32, in press.
46. Oxenkrug, G. F., Anderson, G., Dragovic, L., Blaivas, M., and Riederer, P. (1990b). Circadian rhythm of human plasma melatonin, related indoles and beta receptors: postmortem evaluation. Journal of Pineal Research, in press.
47. Oxenkrug, G. F., Requintina, P., McIntyre, I. M., and Davis R. (1991). Stimulation of rat pineal melatonin synthesis by a single electroconvulsive shock: chronobiol-ogical effect of antidepressant therapy? In 5-Hydroxytryptamine in psychiatry: a spectrum of ideas, (ed. M. Sandler, A. Coppen, and S. Harnett), pp. 110-15. Oxford University Press.
48. Pare, C. and Sandler, M. (1959). A clinical and biochemical study of a trial of iproniazid in the treatment of depression. Journal of Neurology, Neurosurgery and Psychiatry, 22, 247-51.
49. Parfitt, A. G. and Klein, D. C. (1976). Sympathetic nerve terminals in pineal gland protect against acute stress induced increases in N-acetyltransferase activity. Endocrinology, 99, 840-51.
50. Quirion, R. (1984). High density of Ro 5-4864 'peripheral' benzodiazepine binding sites in the rat pineal gland. European Journal of Pharmacology, 102, 559-60.
51. Reuss, S., and Oxenkrug, G. F. (1989). Chemical sympathectomy and clorgyline-induced stimulation of rat pineal melatonin synthesis. Journal of Neural Transmission, 78, 167-72.
52. Sack, R. L., Lewy, A. J., and Hoban, T. M. (1987). Free-running melatonin rhythms in blind people: phase shifts with melatonin and triazolam administration. In Temporal disorders in human oscillatory systems, (ed. L. Rensing, U. an der Heiden, and M. C. Mackey), pp. 219-24. Springer-Verlag, Heidelberg.
53. Sandler, M. (1982). The emergence of tribulin. Trends in Pharmacological Sciences, 3, 471-2.
54. Scheinin, M., Koulu, M., Vakkuri, O., Vuorinen, J., and Zimmer, H. (1990). Moclobemide, an inhibitor of MAO-A, does not increase daytime melatonin levels in normal humans. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 14, 73-82.
55. Simpson, G. S., Frederickson, E., Palmer, R., Edmond, P., Bruce Sloan R., and White, K. (1985). Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine:implications for clinical use. Biological Psychiatry, 20, 680-4.
56. Wehr, T. and Wirz-Justice, A. (1982). Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria, 15, 31-9.
57. Wurtman, R. J. and Ozaki, Y. (1978). Physiological control of melatonin synthesis and secretion mechanisms generating rhythms in melatonin, methoxytryptophol and arginin vasotocin levels. Journal of Neural Transmission, 13, Suppl., 59-70.